Cannara Biotech Inc. (LOVE.V)
CAD 1.35
(0.75%)
CAD 1.35
(0.75%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 17.18 Million CAD | 107.91% |
| 2022 | 9.54 Million CAD | 135.88% |
| 2021 | 3.22 Million CAD | 135.3% |
| 2020 | -9.14 Million CAD | -1.41% |
| 2019 | -10.87 Million CAD | -434.2% |
| 2018 | -1.68 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -632.39 Thousand CAD | -117.91% |
| 2024 Q1 | 4.78 Million CAD | -29.44% |
| 2024 Q3 | -3.32 Million CAD | 657.19% |
| 2023 Q4 | 6.3 Million CAD | 17.2% |
| 2023 Q1 | 1.98 Million CAD | -54.7% |
| 2023 FY | - CAD | 107.91% |
| 2023 Q2 | 1.55 Million CAD | -21.87% |
| 2023 Q3 | 5.38 Million CAD | 246.66% |
| 2022 FY | - CAD | 135.88% |
| 2022 Q4 | 4.38 Million CAD | 98.06% |
| 2022 Q3 | 2.21 Million CAD | 515.03% |
| 2022 Q2 | 360.13 Thousand CAD | -42.91% |
| 2022 Q1 | 630.79 Thousand CAD | -71.77% |
| 2021 Q2 | 389.5 Thousand CAD | 115.96% |
| 2021 Q1 | -2.43 Million CAD | 9.01% |
| 2021 Q3 | 3.03 Million CAD | 679.18% |
| 2021 Q4 | 2.23 Million CAD | -26.38% |
| 2021 FY | - CAD | 135.3% |
| 2020 FY | - CAD | -1.41% |
| 2020 Q4 | -2.68 Million CAD | -55.2% |
| 2020 Q3 | -1.72 Million CAD | 35.62% |
| 2020 Q2 | -2.68 Million CAD | -29.15% |
| 2020 Q1 | -2.07 Million CAD | -48.5% |
| 2019 Q2 | -1.62 Million CAD | -12749.07% |
| 2019 Q3 | -2.28 Million CAD | -40.86% |
| 2019 Q4 | -1.39 Million CAD | 38.8% |
| 2019 FY | - CAD | -434.2% |
| 2019 Q1 | -12.63 Thousand CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.68 Million CAD | 740.984% |
| CanadaBis Capital Inc. | 5.67 Million CAD | -202.704% |
| Decibel Cannabis Company Inc. | 5.67 Million CAD | -202.645% |
| Delivra Health Brands Inc. | 2.35 Million CAD | -630.128% |
| Entourage Health Corp. | -21.39 Million CAD | 180.326% |
| Lifeist Wellness Inc. | -12.76 Million CAD | 234.593% |
| Medicure Inc. | 1.27 Million CAD | -1250.134% |
| PharmaCielo Ltd. | -12.01 Million CAD | 243.005% |
| Rubicon Organics Inc. | 1.94 Million CAD | -782.3% |
| BioSyent Inc. | 9.05 Million CAD | -89.754% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 1507.689% |